134 related articles for article (PubMed ID: 16335666)
1. [Somatostatin receptors--new diagnostic and therapeutic possibilities].
Pawlikowski M
Endokrynol Pol; 2005; 56(1):4-5. PubMed ID: 16335666
[No Abstract] [Full Text] [Related]
2. Pancreatic cancer: does octreotide offer any promise?
Rosenberg L
Chemotherapy; 2001; 47 Suppl 2():134-49. PubMed ID: 11275707
[TBL] [Abstract][Full Text] [Related]
3. Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours.
Angeletti S; Corleto VD; Schillaci O; Marignani M; Annibale B; Moretti A; Silecchia G; Scopinaro F; Basso N; Bordi C; Delle Fave G
Gut; 1998 Jun; 42(6):792-4. PubMed ID: 9691916
[TBL] [Abstract][Full Text] [Related]
4. Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors.
Oda Y; Tanaka Y; Naruse T; Sasanabe R; Tsubamoto M; Funahashi H
Surg Today; 2002; 32(8):690-4. PubMed ID: 12181718
[TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced endocrine gastroenteropancreatic tumours using radiolabelled somatostatin analogues.
Van Eijck CH
Br J Surg; 2005 Nov; 92(11):1333-4. PubMed ID: 16237740
[No Abstract] [Full Text] [Related]
6. Somatostatin Analogues in Neuroendocrine Tumors.
Kulke MH
J Natl Compr Canc Netw; 2016 Mar; 14(3):241-2. PubMed ID: 26957610
[No Abstract] [Full Text] [Related]
7. Role of Somatostatin Analogues in Oncology. European Neuroendocrine Tumor Network (ENET). February 24-27, 2000, Innsbruck, Austria. Proceedings.
Digestion; 2000; 62 Suppl 1():1-108. PubMed ID: 11001649
[No Abstract] [Full Text] [Related]
8. [Somatostatin analogs in the treatment of pancreatic cancer: utopia or feasible alternative?].
Zalatnai A; Pogány V
Orv Hetil; 2000 Oct; 141(43):2333-8. PubMed ID: 11089387
[TBL] [Abstract][Full Text] [Related]
9. The tumour vanishes.
Todd JF; Meeran K
Clin Endocrinol (Oxf); 2000 Dec; 53(6):663-4. PubMed ID: 11155085
[No Abstract] [Full Text] [Related]
10. Octreotide uptake in intracranial metastasis of pancreatic ductal adenocarcinoma origin in a patient with a prolonged clinical course.
Marepaily R; Micheals D; Sloan A; Hatfield J; Adsay V; Joyrich R; Ullah N; Tobi M
Dig Dis Sci; 2009 Jan; 54(1):188-90. PubMed ID: 18985450
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha versus somatostatin or the combination of both in metastatic neuroendocrine gut and pancreatic tumours.
Faiss S; Scherübl H; Riecken EO; Wiedenmann B
Digestion; 1996; 57 Suppl 1():84-5. PubMed ID: 8813478
[TBL] [Abstract][Full Text] [Related]
12. Octreotide.
Lamberts SW; van der Lely AJ; de Herder WW; Hofland LJ
N Engl J Med; 1996 Jan; 334(4):246-54. PubMed ID: 8532003
[No Abstract] [Full Text] [Related]
13. Editorial: somatostatin receptor-based scintigraphy and antitumor treatment--an expanding vista?
Jensen RT
J Clin Endocrinol Metab; 2000 Oct; 85(10):3507-8. PubMed ID: 11061490
[No Abstract] [Full Text] [Related]
14. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
Janson ET; Oberg K
Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
[No Abstract] [Full Text] [Related]
15. Carcinoid of the pancreas.
Migliori M; Tomassetti P; Lalli S; Casadei R; Santini D; Corinaldesi R; Gullo L
Pancreatology; 2002; 2(2):163-6. PubMed ID: 12123097
[TBL] [Abstract][Full Text] [Related]
16. [Somatostatin analogue (octreotide)].
Sano K; Makuuchi M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():674-7. PubMed ID: 11762035
[No Abstract] [Full Text] [Related]
17. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
Hofsli E
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
[TBL] [Abstract][Full Text] [Related]
18. Distribution and functionality of the somatostatin receptor subtypes in acromegaly.
Saveanu A; Gunz G; Dufour H; Enjalbert A; Culler MD; Jaquet P
J Endocrinol Invest; 2003; 26(8 Suppl):4-7. PubMed ID: 15233203
[No Abstract] [Full Text] [Related]
19. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
